Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic. | June 15, 2023
Ad hoc announcement pursuant to Art. 53 LR Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy , a rare,. | June 12, 2023
Survey of Unmet Needs in chronic myeloid leukemia data signal need for amplified patient voice during treatment discussions that balance quality of life , efficacy, and. | June 9, 2023
By Giulia Petroni Novartis s off-patent medicines division Sandoz set out its growth plans as a standalone company following the proposed spinoff, saying it is well positioned to continue. | June 8, 2023
European shares opened lower on
Thursday as rate-sensitive technology shares slipped on
expectations of further interest rate hikes by major central
banks, although gains in Swiss healthcare group. | June 8, 2023